METHODS FOR TREATING MYELODYSPLASTIC SYNDROME WITH EZATIOSTAT
- 专利权人:
- Gail L. Brown
- 发明人:
- Gail L. Brown
- 申请号：
- US13437474
- 公开号：
- US20130035389A1
- 申请日:
- 2012.04.02
- 申请国别(地区):
- US
- 年份:
- 2013
- 代理人:
- 摘要：
- This invention relates to methods, assays, devices and systems for identifying patients having a myelodysplastic syndrome for treatment with ezatiostat or a salt thereof, or evaluating the patients response possibility to the treatment by measuring and evaluating the patients gene expression profile. This invention also relates to methods of treating myelodysplastic syndromes.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- GENE EXPRESSION SIGNATURES ASSOCIATED WITH RESPONSE TO IMATINIB MESYLATE IN GASTROINTESTINAL STROMAL TUMORS AND USE THEREOF FOR PREDICTING PATIENT RESPONSE TO THERAPY AND IDENTIFICATION OF AGENTS WHICH HAVE EFFICACY FOR THE TREATMENT OF CANCER
- Identification of a 5-Gene Expression Signature Predicting Clinical Outcome of Patients with Brain Tumors
- Identification of a 5-Gene Expression Signature Predicting Clinical Outcome of Patients with Brain Tumors
- GENE EXPRESSION SIGNATURE AS A PREDICTOR OF CHEMOTHERAPEUTIC RESPONSE IN BREAST CANCER
- Breast cancer prognosis, prediction of progesterone receptor subtype andprediction of response to antiprogestin treatment based on gene expression
